Resolvin E2: Identification and Anti-Inflammatory Actions: Pivotal Role of Human 5-Lipoxygenase in Resolvin E Series Biosynthesis

Chemistry and Biology

Volumn 13, Issue 11, 2006, Pages 1193-1202

  Tjonahen, Eric ^a   Oh, Sungwhan F ^a,b   Siegelman, Jeffrey ^a   Elangovan, Siva ^b   Percarpio, Katherine B ^a   Hong, Song ^b   Arita, Makoto ^a   Serhan, Charles N ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5S,12R,18R TRIHYDROXY 6Z,8E,10E,14Z,16E EICOSAPENTAENOIC ACID; 5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID; ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; DRUG DERIVATIVE; ICOSAPENTAENOIC ACID; RESOLVIN E2; ZYMOSAN;

ANIMAL; ARTICLE; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NEUTROPHIL; PERITONITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONATE 5-LIPOXYGENASE; DISEASE MODELS, ANIMAL; EICOSAPENTAENOIC ACID; HUMANS; MICE; NEUTROPHILS; PERITONITIS; ZYMOSAN;

MURINAE;

EID: 33751020561     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2006.09.011     Document Type: Article

References (27)

1. Majno G., and Joris I. Cells, Tissues, and Disease: Principles of General Pathology. Second Edition (2004), Oxford University Press, New York
2. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
3. Karp C.L., Flick L.M., Park K.W., Softic S., Greer T.M., Keledjian R., Yang R., Uddin J., Guggino W.B., Atabani S.F., et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat. Immunol. 5 (2004) 388-392
4. Van Dyke T.E., and Serhan C.N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82 (2003) 82-90
5. Levy B.D., Petasis N.A., and Serhan C.N. A role for polyisoprenyl phosphates in intracellular signaling. Nature 389 (1997) 985-990
6. Serhan C.N. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta 1212 (1994) 1-25
7. Bannenberg G.L., Chiang N., Ariel A., Arita M., Tjonahen E., Gotlinger K.H., Hong S., and Serhan C.N. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174 (2005) 4345-4355
8. Gilroy D.W., Lawrence T., Perretti M., and Rossi A.G. Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3 (2004) 401-416
9. Lawrence T., Willoughby D.A., and Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2 (2002) 787-795
10. Albert C.M., Campos H., Stampfer M.J., Ridker P.M., Manson J.E., Willett W.C., and Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346 (2002) 1113-1118
11. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354 (1999) 447-455
12. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21 (2002) 495-505
13. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36 (2001) 1007-1024
14. Lands W.E.M. Diets could prevent many diseases. Lipids 38 (2003) 317-321
15. Serhan, C.N. June 2004. Resolvins: biotemplates for novel therapeutic interventions. U.S. patent US2004/0116408 A1. Filed August 12, 2003.
16. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N.A., and Serhan C.N. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201 (2005) 713-722
17. Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., Blumberg R.S., and Serhan C.N. Resolvin E1, a novel endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against TNBS-induced colitis. Proc. Natl. Acad. Sci. USA 102 (2005) 7671-7676
18. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., and Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192 (2000) 1197-1204
19. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., and Moussignac R.L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J. Exp. Med. 196 (2002) 1025-1037
20. Serhan C.N. Novel omega-3-derived local mediators in anti-inflammation and resolution. Pharmacol. Ther. 105 (2004) 7-21
21. Ochi K., Yoshimoto T., Yamamoto S., Taniguchi K., and Miyamoto T. Arachidonate 5-lipoxygenase of guinea pig peritoneal polymorphonuclear leukocytes. Activation by adenosine 5′-triphosphate. J. Biol. Chem. 258 (1983) 5754-5758
22. Ueda N., Kaneko S., Yoshimoto T., and Yamamoto S. Purification of arachidonate 5-lipoxygenase from porcine leukocytes and its reactivity with hydroperoxyeicosatetraenoic acids. J. Biol. Chem. 261 (1986) 7982-7988
23. Emerson M.R., and LeVine S.M. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase. Brain Res. 17 (2004) 140-145
24. Bafica A., Scanga C.A., Serhan C., Machado F., White S., Sher A., and Aliberti J. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115 (2005) 1601-1606
25. Grosser T., Fries S., and FitzGerald G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J. Clin. Invest. 116 (2006) 4-15
26. Romano M., and Serhan C.N. Lipoxin generation by permeabilized human platelets. Biochemistry 31 (1992) 8269-8277
27. 4 synthesis from arachidonic acid. Proc. Natl. Acad. Sci. USA 81 (1984) 689-693